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Non-invasive early diabetes prediction has been gaining much premarkable over the last decade.  Heart rate variability 
(HRV) is the only non-invasive technique that can predict the future occurrence of the disease. Early prediction of diabetes 
can help doctors start an early intervention. To this end, the authors have developed a computational machine learning 
model to predict type 2 diabetes mellitus (T2DM) risk using heart rate variability features and have evaluated its robustness 
against the HRV of 50 patients data. The electrocardiogram (ECG) signal of the control population (n=40) and T2DM 
population (n=120) have been recorded in the supine position for 5 minutes, and HRV signals have been obtained. The time 
domain, frequency domain, and non-linear features have been extracted from the HRV signal. A decision support system has 
been developed based on a machine learning algorithm. Finally, the decision support system has been validated using the 
HRV features of 50 patients (Control n=10 and T2DM n=40). HRV features are selected for the prediction of T2DM. The 
decision support system has been designed using three machine learning models: Gradient boosting decision tree (GBDT), 
Extreme Gradient boosting (XGBoost), Categorical boosting (CatBoost), and their performance have been evaluated based 
on the Accuracy (ACC), Sensitivity (SEN), Specificity (SPC), Positive predicted value (PPV), Negative predicted value 
(NPV), False-positive rate (FPR), False-negative rate (FNR), F1 score, and Area under the receiver operating characteristic 
curve (AUC) metrics. The CatBoost model offers the best performance outcomes, and its results have been validated on 50 
patients. Thus the CatBoost model can be use as a decision support system in hospitals to predict the risk of T2DM.  
Keywords: Heart rate variability, Type 2 diabetes mellitus, Gradient boosting decision tree, Extreme gradient boosting, 
Categorical boosting 
1 Introduction 
Diabetes mellitus is usually known as diabetes. The 
primary reason behind this disease is that the body 
is unable to metabolize glucose properly. Some 
researchers in diabetes have reported that from 1980 
to 2014, diabetes disease has risen from 4.7% to 
8.5%. The number will further increase to 25%, 51% 
in 2030 and 2045, respectively
1
. There are three types 
of diabetes: • Type 1 diabetes which is found in 
children; in this type, the pancreas cannot produce 
insulin
2,3
 • Type 2 diabetes which is a common type of 
diabetes found in adults. Around 85% of the world 
population has this type of diabetes. It occurs if the 
body cannot convert glucose into energy due to a lack 
of insulin production
4
. • Gestational diabetes which is 
found in pregnant women due to inadequate insulin 
secretion
5
. Although there is no proper cure for 
diabetes, it can be prevented and controlled if early 
indications of diabetes is  possible. An early indication 
of the disease is possible using the HRV signal. HRV 
shows time variation between RR intervals of ECG 
signals. The pacemaker of heart is the sinoatrial node 
(SA) which generates cardiac impulses influenced by 
the autonomous nervous system (ANS). ANS consists 
of sympathetic nervous system (SNS) and 
parasympathetic nervous system (PNS), which control 
the heart rate. SNS and PNS balance the normal heart 
rate which is strongly influenced by different body 
factors. Therefore, the status of ANS can be analyzed 
using the HRV signal. If any disease developed in the 
body, it might affect ANS, so HRV gets affected, and 
an early indication of that disease is possible. HRV is 
a simple and non-invasive measurement technique 
and indicates stages of the diseases. In this study, 
HRV signal has been analyzed mainly using machine 
learning algorithm. The main objective of the study is 
to design a machine learning-based decision support 
system for physicians using HRV features that 
can be used as an initial screening test tool to predict 
T2DM risk. The contributions of the present study are 
————— 
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comprehensive analysis between the three types of 
HRV methods, namely time domain, frequency 
domain, and non-linear method. We have been 
concern about the breathing rate (BR) effect on HRV 
for diabetes prediction. The time domain, frequency 
domain, and non-linear features of HRV, along with 
the breathing rate have been used to predict the risk of 
T2DM. We have proposed a machine learning model 
as a decision support system for the prediction  
of T2DM risk. The proposed model is based  
on real and authentic HRV data. We have proposed  
a cost-effective screening tool to detect the risk  
of T2DM patients. Contribution to the validation of  
the machine learning model on patients (n=50) in  
the hospital. 
 
2 Materials and Methods 
 
2.1 Participants and data collection 
The present study was performed by following the 
protocol given by the Taskforce of the European 
Society for Cardiology and the North American 
Society of Pacing and Electrophysiology
6
. The study 
was conducted at Smt. Kashibai Navale Medical 
College and General Hospital (SKNMCGH) Pune, 
Maharashtra, India, in collaboration with College  
of Engineering Pune (COEP), Pune India. The 
institutional ethical committee of SKNMCGH has 
approved the study. The participants were selected 
from the OPD of SKNMCGH by following American 
Diabetic Association guidelines
7
. Patients with a history 
of any acute or chronic diseases were safely excluded 
from the study. Before the electrocardiogram (ECG) 
recording, the procedure and objective of the study 
were informed to the participant, and informed 
consent was received. The ECG of selected subjects 
was recorded in the supine position for 15 minutes, 
and the last 5-minute segment was used for HRV 
analysis as shown in Fig. 1. The ECG was recorded 
using the data acquisition tool Chronovisor HRV DX 
system at sampling frequency 1000Hz, and HRV  
was analyzed using Chronovisor HRV software  
suite 1.1.487.  
 
2.2 Feature extraction 
In this section, the time domain, frequency domain, 
and non-linear features used for T2DM risk prediction 
have been discussed. The HRV features were derived 
using the RR time series interval of ECG signals.  
 
2.2.1 Time domain features 
In the time-domain analysis, simple statistical 
features were derived. The mean HR and mean RR 
features were obtained from the RR interval. The RR 
interval variability was represented using a standard 
deviation of normal to normal interval (SDNN) and 
root mean square standard deviation (RMSSD) 
features as presented in Table 1. Another important 
feature is the breathing rate (BR), which shows the 
effect of respiration on HRV and is represented in 
beats per minute. It is very important to consider BR 
while analyzing the HRV. The statistical difference 
between control and T2DM subjects was calculated 
using the Mann-Whitney U test. Statistical software 
tool Epi. Info. 7 was used for data analysis. In the 
present study, a p-value <0.05 was considered 
statistically significant, and the data were presented in 




2.2.2 Frequency domain feature 
In the frequency domain method, a power spectral 
density estimator (PSD) calculates the frequency 
 
 
Fig. 1 — ECG recording in a supine position. 
Table 1 — Time-domain features 
Features Control (n=40) T2DM (n=120) p-Value 
mean HR 71.73 ± 9.95 79.88 ± 12.09 0.0001# 
mean RR 851.28 ± 111.26 767.84 ± 114.41 0.0001# 
SDNN 71.82 ± 33.70 31.26 ± 15.08 <0.0001# 
RMSSD 77.21 ± 54.69 70.05 ± 37.89 0.9529 
BR 12.92 ± 2.71 15.15 ± 3.31 0.0001# 
#-Significant difference, n= Number of samples, Mean HR- Average heart rate, Mean RR- Average RR interval, SDNN- Standard 
deviation of NN interval, RMSSD- Root mean square standard deviation, BR- Breathing rate 
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component of the RR interval series. The PSD 
estimation can be carried out using the Fast Fourier 
Transform method (FFT) or the Autoregressive 
modeling method (AR model). However, considering 
the complexity of the AR model, the results of the 
FFT method were used. The PSD estimator 
decomposes the RR interval into a frequency 
component using the FFT method
9
. The power in the 
frequency range of 0.04 to 0.15Hz is defined as a low-
frequency power band. The power in the frequency 
range of 0.15 to 0.4Hz is defined as a high-frequency 
power band. The power in the frequency band was 
calculated in absolute (ms
2
) and normalized unit (nu). 
The LF and HF power reflect the sympathetic and 
parasympathetic activity. In this study, total power 
(TP), LF power, HF power, LF nu, HF nu, and LF to 
HF power ratio were analyzed. The statistical 
difference between frequency-domain features of 
control and T2DM has been mentioned in Table 2. 
 
2.2.3 Non-linear features 
The nature of the biological signal is non-linear. 
Thus, the study of non-linear dynamics is important 
for analysis. The non-linear feature used in this study 
is as follows: Poincare plot, Detrended fluctuation 
analysis (DFA), Approximate entropy (AppEN),  
and Sample entropy (SampEN). The significant 
difference between non-linear features of control and 
T2DM subjects are presented in Table 3.  
 
2.2.3.1 Poincare plot 
The Poincare plot represents the present RR 
interval and the next RR interval, which shows the 
non-linear behaviors of RR interval variability
9
.  
The Poincare plot can be interpreted using standard 
deviation 1 (SD1), representing the short-term 
variability in RR interval, and standard deviation  





2.2.3.2 Detrended fluctuation analysis (DFA) 
DFA is used to assess the self-similarity properties 
of the RR interval. It also measures the correlation 
between different time series signals
11
. The fluctuation 
in the time series signal is represented by parameter α. 
Alpha (α) is called as the scaling exponent. The time-
series signal is integrated and divided into segments 
of length 𝑛 and 𝑥𝑛 𝑘  a least-square line is applied to 
each segment. Next, the integrated time series 𝑥(𝑘)  is 
detrended from the next least square line of each 
segment.  The detrended time series of RR interval is 
calculated by: 
 
𝐹 𝑛 =  
1
𝑁
 (𝑥 𝑘 − 𝑥𝑛 𝑘 )
2𝑁
𝐾=1                        … (1) 
 
DFA is plotted on a double log graph, and a linear 
relationship indicates the presence of fractal scaling. 
The value of α is closer to 1 for control subjects, and 
it may vary with disorders.  
 
2.2.3.3 Approximate entropy (AppEN) 
AppEN measures the regularity of the time-series 
signal. The value of AppEN is larger in the case of  
a control subject compared to diabetes subjects
12,13
.  
It is calculated as: 
Table 2 — Frequency domain features 
Features Control (n=40) T2DM (n=120) p-Value 
TP 3289.23 ± 2817.26 706.99 ±758.30 <0.0001# 
LF power 807.54 ± 688.18 154.02 ± 194.49 <0.0001# 
HF power 933.58 ± 997.94 219.53 ± 372.32 0.0001# 
LF nu 51.08 ± 17.22 45.45 ± 15.78 0.039# 
HF nu 48.19 ± 17.22 59.55 ± 62.89 0.0516 
LF/HF 1.39 ± 0.99 1.59 ± 5.47 0.0477# 
#-Significant difference, n= Number of samples, TP- Total power, LF- Low frequency, HF- High frequency, nu- Normalized unit 
 
Table 3 — Non-linear features 
Features Control (n=40) T2DM (n=120) p-Value 
SD1 42.76 ± 26.69 21.70 ±12.78 0.0001# 
SD2 90.63 ± 42.22 38.06 ± 19.13 0.0001# 
DFA α1 0.92 ± 0.24 0.89 ± 0.17 0.4067 
DFA α2 1.13 ± 0.16 1.13 ± 0.20 0.5596 
AppEN 1.45 ± 0.31 1.35 ± 0.33 0.1233 
SampEN 42.76 ±26.69 21.70 ± 12.78 0.0001# 
#-Significant difference, n= Number of samples, SD- Standard deviation, DFA- Detrended fluctuation analysis, AppEN- Approximate 
entropy, SampEN- Sample entropy 
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𝑚  𝑟 −𝑁−𝑚+1𝑖=1
1𝑁−𝑚𝑖=1𝑁−𝑚𝑙𝑜𝑔𝐶𝑖𝑚+1(𝑟)       … (2) 
where, 𝐶𝑚
𝑖  is the correlation integral 
 
2.2.3.4  Sample entropy (SampEN) 
SampEN measures the complexity of the time-
series signal. It is actually like approximate entropy 
but a more refined version
12,13
. Higher values of 
SampEN represent the more irregularity in a time-
series signal. Irregularity in a time series signal 
indicates the status of a patient. In the control subject, 
it was noted that irregularity is more as compared to 
diabetes subject. The sample entropy values can be 
calculated by: 
 
𝑆𝑎𝑚𝑝𝐸𝑁 𝑘, 𝑟,𝑁 = −𝑙𝑛  
𝐴(𝑘)
𝐵(𝑘−1)
    … (3) 
 
The variable 𝐴(𝑘) and 𝐵(𝑘) for all lengths 𝑘 up to 
𝑚 and keeps track of template matches. In this study, 
𝑘 = 0,1,2,… . .𝑚 − 1 with 𝐵 0 = 𝑁, the length of 
the input time-series signal. 
 
2.3 Dataset introduction 
The present study uses two in-house HRV datasets. 
The dataset D1 comprises a control subject (n=40) 
aged 27.37 ± 6.73 and the diabetes subject (n=120) 
aged 53.59 ± 11.01. The dataset D2 comprised a 
control subject (n=10) aged 26.4 ± 6.29, and the 
diabetes subject (n=40) aged 54.60 ± 8.94. The 
dataset D1 is used to train the machine learning 
model, whereas dataset D2 is used to evaluate the 
performance of the machine learning model trained 
using dataset D1.  
 
2.4 Data pre-processing 
The preprocessing step includes outlier rejection 
and normalization of the dataset, which are described 
as follows: 
The outliers are the observation that is deviated 
from their normal range
14
. The first criteria to remove 
outlier from the dataset is - 1). The data that falls 
outside the 𝑥  ± 3𝜎 and 2). The data that falls outside 
of 1.5 times of an interquartile range, above 3
rd
 
quartile and below 1
st
 quartile, are considered an 
outlier. The mathematical formulation of the outlier 




𝑥, 𝐼𝑓  > 𝑥  ± 3𝜎
𝑥, 𝐼𝑓 𝑄1 − 1.5 × 𝐼𝑄𝑅 × ≤ 𝑥 ≤  𝑄3 + 1.5 × 𝐼𝑄𝑅
𝑅𝑒𝑗𝑒𝑐𝑡, 𝑂𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
  
 … (4) 
where, 𝑥 represents the attribute of the feature vector 
in the 𝑛 −dimensional space, 𝑥 ∈  𝑆𝑛 . 𝑥 , 𝜎, 𝑄1, 𝑄3, 
𝐼𝑄𝑅 is the average, standard deviation, first quartile, 
third quartile, and interquartile range of  𝑥 ∈  𝑆𝑛 . 
The min-max normalization technique was used  
for normalization, i.e., rescaling the attribute value 
between zero mean and unit variance to achieve the 
normal distribution
15
. The mathematical representation 





 𝑝 − 𝑞 + 𝑞  … (5) 
 
where, 𝑥 is the 𝑛 - dimensional attribute of the 
feature vector, 𝑥 ∈  𝑆𝑛 , 𝑝 is the new maximum value, 
and 𝑞 is the new minimum value 
 
2.5 Machine learning models 
The dataset consists of a control subject and a 
diabetes subject. Thus, this problem can be considered 
as a binary classification assignment. The python data 
manipulation tool was used for implementing a 
machine learning model. We used three ensemble 
boosting algorithms in our study. The details about 
the algorithm are as follows: 
 
2.5.1 Gradient boosting decision tree (GBDT) 
Friedman extended the adaptive boosting concept 
by introducing the Gradient boosting decision tree 
(GBDT)
16
. The goal of GBDT is to improve the 
performance of the model by updating the weight of 
the samples during the training process. GBDT 
involves three elements: 1) optimization of the loss 
function, 2). Use of a weak learner to improve the 
performance, 3) develops an additive model to 
minimize the loss function.  
The GBDT model initialized with the constant 
value, which minimizes the loss function. In each 
iteration of the training process, a negative gradient of 
the loss function is assessed as the residual value of 
the present model, and a new tree is formed to fit the 
residual. This new tree is trained to fit the present 
residual and added to the previous model. After this 
process, the residual is updated, and the process 
continues iteratively until the user-set maximum 
number of iteration conditions is reached.  The GBDT 
algorithm is as follows: 
 
Algorithm 1 — Gradient boosting decision tree 
Input: Training set 
  𝑥1 ,𝑦1 ,  𝑥2 ,𝑦2 …… (𝑥𝑁 ,𝑦𝑁) , 𝑥 ∈  𝑆
𝑛 , y  ∈
 𝑆𝑛 , Loss function 𝐿(𝑦, 𝑓 𝑥 ), 
Output: Updated new tree 𝑓1(𝑥) 
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(1) Initialize model with a constant value 




(2) For m= 1, 2, 3….𝑀 
(a) Calculate the residual 
𝑟𝑒𝑠 = −
𝜕𝐿(𝑦𝑖 ,𝑓 𝑥𝑖 )
𝜕𝑓  𝑥𝑖 
 , 𝑖 = 1,2,3… .𝑁 
(b) Fit a tree 𝐶𝑚𝑓  with the residual 𝑟𝑒𝑠 using the 
training set  𝑥𝑖 , 𝑟𝑒𝑠)  
(c) 𝛼𝑚𝑓 = 𝑎𝑟𝑔𝑚𝑖𝑛  𝐿(𝑦𝑖 ,𝑓𝑚−1 𝑥𝑖 + 𝛼)
𝑛
𝑖=1  
(d) Update the current model by  
𝑓𝑚  𝑥 =  𝑓𝑚−1 𝑥 + 𝐶𝑚𝑓𝛼𝑚𝑓  
 
(3) 𝑓1 𝑥 = 𝑓𝑚  𝑥  
 
 
2.5.2 Extreme gradient boosting (XGBoost) 
The XGBoost is a more regularized form of 
Gradient boosting proposed by Tianqi Chen in 2016
17
. 
The mathematics behind XGBoost is the same as the 
GBDT, but it shows the improved speed of tree 
construction and tree searching. The strength of 
XGBoost is parallel computing, L1 and L2 
regularization, and second-order derivative of the loss 
function.  It uses the advanced regularization of L1 
and L2 algorithms, which improves the generalization 
capabilities of the model. The optimized XGBoost 
model with the N decision tree is represented by  
Eq. (6). 
 




  … (6) 
 
The loss function is given by Eq. (7) 
𝐿 𝑓 =  𝑙( 𝑦𝑖 ,𝑦𝑖) +  𝛽 𝑓   … (7) 
 
The first term represents the loss function which 
measures the predicted output 𝑦𝑖  and tree output 𝑦𝑖 . 
The second term 𝛽 represents the regularization used 
as a penalty to avoid overfitting of the model. The 
𝛽 can be written as- 
 
𝛽 𝑓 = 𝛼𝑇 +
1
2
 𝑤 2  … (8) 
 
where, 𝑇 is the number of leaf nodes of the trees, and 
𝑤 is the weight of the leaf nodes. The final loss 
function equation is represented as- 
 












 … (9) 
where, 𝑚𝑖  , 𝑛𝑖  represent 1
st
 order, the 2
nd
 Gradient 
of the loss function, respectively. The parameters 𝜇 
and 𝛼 represent the degree of regularization, which 
provides gradient direction to minimize the loss 
function and avoid overfitting.  
 
2.5.3 Categorical boosting (CatBoost) 
Catboost is a new machine learning method  
based on the Gradient boosting decision tree (GBDT), 
and Y and ex first proposed it in 2018
18
. It supports 
numerical, categorical, and text features. Various 
boosting techniques can solve the problem associated 
with the heterogeneous features, but CatBoost can 
handle the categorical data. CatBoost has the 
following advantages over the GBDT algorithm: 
(1) It deals with the categorical data and uses the 
whole dataset for training. The GBDT uses 
Greedy target based statistics (GTBS), which can 
replace the categorical features with the average 
label, leading to overfitting the model. CatBoost 
adds the prior weight to GTBS, which reduces the 
overfitting of the model. For example, we have a 
dataset D with the features 𝐷 =  𝑥𝑖 ,𝑦𝑖   , 𝑖 = 1,
2, 3…𝑛, if a permutation is 𝜎 = (𝜎1,𝜎2 ……𝜎𝑛) 
then 𝑥𝜎𝑝 ,𝑘  is substituted with 
 
  𝑥𝜎𝑗 ,𝑘=𝑥𝜎𝑝 ,𝑘  𝑌𝜎𝑗 + 𝛾∙𝑃
𝑝−1
𝑗=1
  𝑥𝜎𝑗 ,𝑘=𝑥𝜎𝑝 ,𝑘  𝑌𝜎𝑗 + 𝛾
𝑝−1
𝑗=1
  … (10) 
 
where, 𝑃 is the prior value, and 𝛾 is the weight of the 
prior value. This method reduces the overfitting of the 
model. 
(2) CatBoost combines multiple categorical features. 
When categorical features are converted into 
numerical values, it may lose some information. 





(3) In GBDT, each weak learner is trained based on 
the Gradient of the previous learner. Therefore, 
the Gradient of a weak learner in each iteration is 
biased, leading to overfitting the model. CatBoost 
can overcome this gradient bias using ordered 
boosting. Ordered boosting helps to avoid the 
predicted shift caused by gradient bias
18
. The 
algorithm of order boosting is as follows: 
 
Algorithm 2 — Ordered boosting 
Input:  𝑋𝑘 , 𝑌𝑘  𝑘
𝑛  , 𝐼 ;  𝜎 ← permutation of  1, 𝑛  
𝑀𝑖 ← 0 for 𝑖 =   1… .𝑛; 
for 𝑡 ← 1 to 𝐼 do 
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       for 𝑖 ← 1  to 𝑛  do 
𝑟𝑖 ←  𝑦𝑖  −𝑀𝜎 𝑖 −1(𝑋𝑖); 
       for 𝑖 ← 1  to 𝑛  do  
∆𝑀 ←   𝐿𝑒𝑎𝑟𝑛 𝑀𝑜𝑑𝑒𝑙   𝑋𝑗 , 𝑟𝑗  : 𝜎 𝑗 ≤ 𝑖  ; 
𝑀𝑖 ← 𝑀𝑖  + ∆𝑀 
return  𝑀𝑛  
 
Final model uses 𝑀𝑖  to obtain the unbiased 
Gradient boosting by separately training the model 
with and without sample 𝑋𝑖  . 
 
2.6 Model optimization 
The dataset was divided into 80% for training, and 
the other 20% were used for testing. We applied a 
grid search approach and 5-fold inner cross-validation 
to optimize the hyperparameters of the machine 
learning model. The inner 5-fold cross-validation was 
performed only on the training dataset. The optimized 
parameters of GBDT were as follows: ‘subsample’, 
‘max_features’, ‘learning_rate’, ‘criterion’, ‘random_state’, 
‘loss.’ The optimized parameter was used for XGBoost 
were as follows: ‘max_depth’, ‘colssample_bytree’, 
‘min_child_weight’, ‘learning_rate’, ‘random_state’, 
‘gamma’. The following are the CatBoost parameter 
used for optimization: ‘n_jobs’, ‘n_estimators’, 
‘max_depth’, ‘criterion’, ‘random_state’, ‘bootstrap’. 
All the possible combinations of these hyperparameters 
were used before training and tested on the model. 
The machine learning model, which shows the best 
performance with the hyperparameters, was considered 
as the best model. The framework of the study is 
shown in Fig. 2. 
2.7 Performance evaluation 
The performance of the machine learning model 
was evaluated based on the various performance 
evaluation metrics: Accuracy (ACC), sensitivity 
(SEN), specificity (SPC), positive predicted value 
(PPV), negative predicted value (NPV), false-positive 
rate (FPR), false negative rate (NFR), F1 score, and 
area under the receiver operating characteristic curve 
(AUC). These metrics were evaluated using true 
positive (TP), false positive (FP), true negative (TN), 
and false-negative (FN).  The performance metrics are 
shown in Table 4. 
 
3 Results and Discussion 
This section presents the results of the selected 
HRV features to predict the risk of T2DM. In this 
study, we have taken two datasets. The dataset D1 
consists of 40 normal subjects and 120 diabetes 
subjects. The dataset D2 consists of 10 normal 
subjects and 40 diabetes subjects. The HRV features 
from dataset D1 were used to train the machine 
 
 
Fig. 2 — A complete framework of the study. 









F1 Score 2TP/(2TP+FP+FN) 
AUC The area under the ROC curve 
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learning model, whereas dataset D2 was used as test 
data and used to evaluate machine learning models' 
performance. We have trained the machine learning 
model by the HRV features from dataset D1 and 
divided it into training data and testing data. The 
various traditional machine learning algorithms like 
Decision tree, Random forest, Naive Bayes, Support 
vector machine, and k-nearest neighbors were 
evaluated. The traditional machine learning algorithm 
has shown a good performance while training, but 
when dataset D2 was applied as test data, their 
predictive ability was lacking. Thus, the three best 
machine learning models GBDT, XGBoost, and 
CatBoost, which performed very well on train data 
and test data, were selected for the study. Before the 
training of the machine learning model was optimized 
using hyperparameters. The machine learning model 
results were evaluated based on performance 
measures. Performance of the model GBDT, XGBoost, 
and CatBoost using dataset D1 is shown in Table 5. 
It can be observed that the optimized CatBoost 
model performs well as compared to other models and 
yields an accuracy of 91.6%, the sensitivity of 97.1%, 
the specificity of 76.9%, PPV of 91.8%, NPV of 
90.9%, FPR of 0.23, FNR of 0.02, f1 score of 0.94 
and AUC of 0.87. It was noted that the FPR and  
FNR of the CatBoost model were less, which 
indicates the ability of the model to predict correct 
classes.  
The receiver operating characteristic (ROC) curve 
is another meaningful visualization way to compare 
the diagnostic performance of different models. It is  
a plot of ‘sensitivity (TPR) versus ‘1-Specificity’ 
(FPR)
19
. ROC indicates the performance of individual 
models, and the area under the ROC lies between  
0.5 to 1, shows the classification ability. The AUC 
near to 1 represents the best machine learning model 
performance. ROC curves for GBDT, XGBoost, and 
CatBoost are given in Fig. 3.  
 
3.1 Predictive ability evaluation and validation of the model 
TheCatBoost model has shown better results on 
dataset D1. Now to know its predictive ability on 
unknown data, test data, or actual patient data, we 
have been using dataset D2. The dataset D2 was the 
test data for the CatBoost model. We hypothesized 
that the machine learning model trained to segregate 
two groups of control and diabetes based on the HRV 
features of dataset D1 would also differentiate the 
HRV features of dataset D2 into control and diabetes 
groups. Thus, HRV features of dataset D2 were used 
as input features for all the machine learning models 
which were trained using dataset D1.  
The results given by the machine learning models 
were noted, and accordingly, true positive, false 
positive, true negative, and false negative were 
manually calculated. When the HRV features of 
dataset D2 were applied to the GBDT machine 
learning model trained using dataset D1, the values of 
true positive: 36, false-positive: 4, false-negative: 3, 
true negative: 7 were noted. When the HRV features 
of dataset D2 were applied to the XGBoost machine 
learning model trained using dataset D1, the values of 
true positive: 38, false-positive: 2, false-negative: 2, 
true negative: 8 were observed. When the HRV 
features of dataset D2 were applied to the CatBoost 
machine learning model trained using dataset D1, the 
values of true positive: 39, false-positive: 1, false-
negative: 1, true negative: 9 were obtained. Thus, the 
CatBoost machine learning model has the highest 
predictive ability. The performance assessment of 
dataset D2 applied to the machine learning model 
developed using dataset D1 is shown in Table 6. 
Table 5 — Performance evaluation of dataset D1 
Model ACC (%) SEN (%) SPC (%) PPV (%) NPV (%) FPR FNR F1 Score AUC 
GBDT 84.3 95.8 50 85.1 80 0.50 0.04 0.90 0.72 
XGBoost 87.5 91.6 75 91.6 75 0.25 0.08 0.91 0.83 




Fig. 3 — Area under ROC plot of the optimized model. 
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It can be observed that the test data from dataset 
D2 fed to the CatBoost machine learning model 
trained with dataset D1 has shown the highest ACC of 
96%, SEN of 97.5%, SPC of 90%, PPV of 97.5%, 
NPV of 90%, FPR of 0.10, FNR of 0.02, F1 score of 
0.97 and AUC of 0.93 as compared to other 
algorithms. The CatBoost model trained with dataset 
D1 has correctly predicted 39 diabetes subjects out  
of 40 diabetes subjects and 9 control subjects out of 
10 control subjects. Thus, the FPR and FNR were 
reduced. The area under the ROC curve of all three 
models is shown in Fig. 4. 
We have achieved the highest accuracy, sensitivity, 
and specificity with the CatBoost model. In some 
studies, the time domain and frequency domain 
characteristics of HRV have been used to predict 
diabetes. So far, to the best of our knowledge, no 
researcher has considered the time domain, frequency 
domain, and non-linear features along with the breathing 
rate factor in a single study. Various authors have 
achieved good prediction accuracy, but no study has 
implemented their machine learning model on actual 
patients. Thus, the implementation of the machine 
learning model on patients assures the validation of the 
model. We have found that most of the HRV features 
values are reduced in diabetic subjects compared to the 
control subjects, and their significant difference can help 
to predict T2DM at earlier stages.  
The basic HRV features are the time-domain 
features. The author AL-Hazimi et al.
20
 have found 
that the time domain features like SDNN, RMSSD, 
etc., were reduced in the diabetes group compared to 
the control group. Pfeifer et al.
21
 have observed that 
parasympathetic activity was reduced in diabetes 
patients. Schroeder et al.
22
 have found decreased 
time-domain parameters in the diabetes group. 
Kirvela et al.
23
 performed time domain and frequency 
domain analysis of HRV and found a significant 
reduction in these parameters. 
The author Seyd et al.
24
 performed time domain 
and frequency domain HRV analysis. It was noted 
that the time domain parameters like mean HR, mean 
RR, SDNN, RMSSD, and the frequency domain 
parameter like TP, LF power, HF power were lower 
in diabetes patients. Chemla D et al.
25
 used FFT and 
the autoregressive model to analyze the effect of HRV 
on diabetes patients. Javorka et al.
26
 used linear and 
non-linear parameters used to predict type 1 diabetes 
mellitus. Faust et al.
27
 analyzed the time domain, 
frequency domain, non-linear features and found that 
non-linear features provide prominent results in  
the diagnosis of diabetes. Acharya et al.
28,29
 have 
proposed diabetes integrated index (DII) using non-
linear HRV features, and an accuracy of 86% was 





 have used higher-order spectrum 
(HOS) features to predict diabetes and obtained  
an accuracy of 79.9%, 90.5%, respectively. The 
summaries of diabetes prediction using HRV features 
are given in Table 7. 
The best machine learning model was obtained 
using the CatBoost algorithm. Thus, this model can be 
considered as a decision support system for healthcare 
professionals. The graphical user interface (GUI) with 
the backend programming of the CatBoost algorithm 
was implemented using the python software as shown 
in Fig. 5. The user can manually extract the HRV 
features and enters the values of HRV features 
through the GUI. After clicking on submit button, 
users will be notified of the results as control or 
T2DM risk. Based on the results, patients will be 
advised to communicate with the doctors. 
Table 6 — Performance evaluation of dataset D2 on optimized model 
Model ACC (%) SEN (%) SPC (%) PPV (%) NPV (%) FPR FNR F1 Score AUC 
GBDT 86 92.3 63.6 90 70 0.36 0.07 0.91 0.77 
XGBoost 92 95 80 95 80 0.10 0.05 0.95 0.87 




Fig. 4 — Area under ROC plot of results obtained from the 
optimized model on test data. 
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3.2 Consent regarding small sample size of control and 
diabetes dataset 
The designed model can be considered as a 
preliminary model. We attempt to design the machine 
learning model with real and authentic data. However, 
it is challenging to find control and diabetes subjects 
unless they go through the pathological test. So it is 
difficult to increase the sample of control and diabetes 
subjects in less time constraint. We are still working 




Type 2 diabetes mellitus is a long-term disease. 
Early prediction of diabetes can help doctors as well 
as patients take preventive measures. We have seen 
that HRV features have reduced in the diabetes group, 
and this reduction starts in early stages of diabetes. 
Thus, HRV features can be helpful to predict disease 
at an early stage. We can conclude that the CatBoost 
machine learning model is a better model to classify 
diabetes patients based on different performance 
metrics like ACC, SEN, SPC, PPV, NPV, FPR, FNR, 
F1 score, and AUC. The machine learning model was 
validated on 50 patients, and it has correctly predicted 
48 patients out of 50 patients. Therefore, we can 
recommend this model as a decision support system 
to predict the risk of T2DM. 
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